Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Laude MC"'
Autor:
Belhabri A; Department of Hematology, Leon Berard Cancer Center, Lyon, France., Heiblig M; Department of Hematology, University Hospital Lyon Sud, Pierre Benite, France., Morisset S; Biostatistics Department, Leon Berard Cancer Center, Lyon, France., Vila L; Department of Hematology, Leon Berard Cancer Center, Lyon, France., Santana C; Department of Hematology, Leon Berard Cancer Center, Lyon, France., Nicolas-Virelizier E; Department of Hematology, Leon Berard Cancer Center, Lyon, France., Hayette S; Department of biology - GHS, University Hospital Lyon Sud, Pierre Benite, France., Tigaud I; Department of biology - GHS, University Hospital Lyon Sud, Pierre Benite, France., Plesa A; Department of biology - GHS, University Hospital Lyon Sud, Pierre Benite, France., Labussiere-Wallet H; Department of Hematology, University Hospital Lyon Sud, Pierre Benite, France., Sobh M; Research Advisor, Faculty of Medicine, University of Ottawa, Ottawa, Canada., Michallet AS; Department of Hematology, Leon Berard Cancer Center, Lyon, France., Marie B; Department of Hematology, University Hospital Lyon Sud, Pierre Benite, France., Nicolini FE; Department of Hematology, Leon Berard Cancer Center, Lyon, France., Guillermin Y; Department of Hematology, Leon Berard Cancer Center, Lyon, France., Gaëlle F; Department of Hematology, University Hospital Lyon Sud, Pierre Benite, France., Lebras L; Department of Hematology, Leon Berard Cancer Center, Lyon, France., Rey P; Department of Hematology, Leon Berard Cancer Center, Lyon, France., Jauffret-Bertholon L; Department of Hematology, Leon Berard Cancer Center, Lyon, France., Laude MC; Department of Hematology, Leon Berard Cancer Center, Lyon, France., Sandrine L; Department of Hematology, University Hospital Lyon Sud, Pierre Benite, France., Michallet M; Department of Hematology, Leon Berard Cancer Center, Lyon, France.
Publikováno v:
Cancer medicine [Cancer Med] 2023 Aug; Vol. 12 (16), pp. 16929-16944. Date of Electronic Publication: 2023 Aug 07.
Autor:
Nicod C; Univ. Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, RIGHT Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, F-25000 Besançon, France., da Rocha MN; Univ. Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, RIGHT Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, F-25000 Besançon, France; CanCell Therapeutics, 25000 Besançon, France., Warda W; Univ. Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, RIGHT Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, F-25000 Besançon, France; CanCell Therapeutics, 25000 Besançon, France., Roussel X; Univ. Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, RIGHT Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, F-25000 Besançon, France; Department of Hematology, CHU Besançon, F-25000 Besançon, France., Haderbache R; Univ. Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, RIGHT Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, F-25000 Besançon, France., Seffar E; Univ. Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, RIGHT Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, F-25000 Besançon, France., Trad R; Univ. Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, RIGHT Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, F-25000 Besançon, France., Bouquet L; Univ. Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, RIGHT Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, F-25000 Besançon, France., Goncalves M; Univ. Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, RIGHT Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, F-25000 Besançon, France; Lymphobank S.A.S.U, F-25000 Besançon, France., Bosdure L; Univ. Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, RIGHT Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, F-25000 Besançon, France., Laude MC; Univ. Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, RIGHT Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, F-25000 Besançon, France., Guiot M; Univ. Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, RIGHT Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, F-25000 Besançon, France., Ferrand C; Univ. Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, RIGHT Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, F-25000 Besançon, France; CanCell Therapeutics, 25000 Besançon, France., Deschamps M; Univ. Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, RIGHT Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, F-25000 Besançon, France; CanCell Therapeutics, 25000 Besançon, France. Electronic address: christophe.ferrand@efs.sante.fr.
Publikováno v:
Current research in translational medicine [Curr Res Transl Med] 2023 Apr-Jun; Vol. 71 (2), pp. 103385. Date of Electronic Publication: 2023 Feb 04.
Autor:
Dumontet C; Hospices Civils de Lyon, Lyon, France.; CRCL, UMR INSERM 1052/CNRS 5286/University of Lyon-France, Lyon, France., Demangel D; Hospices Civils de Lyon, Lyon, France., Galia P; Hospices Civils de Lyon, Lyon, France., Karlin L; Hospices Civils de Lyon, Lyon, France., Roche L; Hospices Civils de Lyon, Lyon, France., Fauvernier M; Hospices Civils de Lyon, Lyon, France., Golfier C; Hospices Civils de Lyon, Lyon, France., Laude MC; Hospices Civils de Lyon, Lyon, France., Leleu X; Hematology Department, CHU Poitiers, Poitiers, France., Rodon P; Hematology Department, CH Périgueux, Périgueux, France., Roussel M; IUC-Oncopôle, Toulouse, France., Azaïs I; Hematology Department, CHU Poitiers, Poitiers, France., Doyen C; UCL Mont-Godinne, Louvain, Belgium., Slama B; Clinical Hematology Department, CH Avignon, Avignon, France., Manier S; Hematology Department, CHRU, Lille, France., Decaux O; Hematology Department, CHU Rennes, Inserm UMR1236, Rennes, France., Pertesi M; Genetic Cancer Susceptibility, International Agency for Research on Cancer, Lyon, France.; Department of Laboratory Medicine, Hematology and Transfusion Medicine, Lund, Sweden., Beaumont M; Hematology Department, CHU Dunkerque, Dunkerque, France., Caillot D; Clinical Hematology Department, Hôpital F. Mitterrand, CHU Dijon, Dijon, France., Boyle EM; Perlmutter Cancer Center, NYU Langone Health, New York, New York, USA., Cliquennois M; Hospitals Organization of Catholic Institute, Lille, France., Cony-Makhoul P; CH Annecy Genevois, Pringy, France., Doncker AV; Private Hospital Sévigné, Cesson-Sévigné, France., Dorvaux V; Clinical Hematology Department, CHR Metz-Thionville, Metz-Thionville, France., Petillon MO; Intergroupe Francophone du Myélome, France., Fontan J; Hematology Department, CHU Besançon, Besançon, France., Hivert B; Hospitals Organization of Catholic Institute, Lille, France., Leduc I; Hematology Department, CH d'Abbeville, Abbeville, France., Leyronnas C; Daniel Hollard Institute-GHM-Grenoble, Grenoble, France., Macro M; Hematology Department, CHU Caen, Caen, France., Maigre M; Internal Medicine Department, CH Chartres, Chartres, France., Mariette C; Hematology Department, CHU Grenoble, Grenoble, France., Mineur P; Clinical Hematology Department, Grand Hôpital de Charleroi, Charleroi, Belgium., Rigaudeau S; Hematology Department, CH Versailles, Versailles, France., Royer B; Clinical Hematology and Cell Therapy Department, Amiens, France., Vincent L; Clinical Hematology Department, CHU Montpellier, France., Mckay J; Genetic Cancer Susceptibility, International Agency for Research on Cancer, Lyon, France., Perrial E; CRCL, UMR INSERM 1052/CNRS 5286/University of Lyon-France, Lyon, France., Garderet L; HU PITIE SALPETRIERE APHP, Paris, France.; Centre de Recherche Saint-Antoine-Team Hematopoietic and Leukemic Development, Sorbonne Université-INSERM, UMR_S 938, Paris, France.
Publikováno v:
American journal of hematology [Am J Hematol] 2023 Feb; Vol. 98 (2), pp. 264-271. Date of Electronic Publication: 2023 Jan 01.
Autor:
Laude MC; Claude Bernard University, Lyon, France., Lebras L; Department of Hematology and Medical Oncology, Centre Léon Bérard, Lyon, France., Sesques P; Department of Hematology, Hospices Civils de Lyon, Lyon, France., Ghesquieres H; Department of Hematology, Hospices Civils de Lyon, Lyon, France., Favre S; Department of Hematology and Cell Therapy, University Hospital of Bordeaux, Bordeaux, France., Bouabdallah K; Department of Hematology and Cell Therapy, University Hospital of Bordeaux, Bordeaux, France., Croizier C; Department of Hematology and Cell Therapy, Estaing University Hospital, Clermont-Ferrand, France., Guieze R; Department of Hematology and Cell Therapy, Estaing University Hospital, Clermont-Ferrand, France., Drieu La Rochelle L; Department of Hematology and Cell Therapy, University Hospital of Tours, Tours, France., Gyan E; Department of Hematology and Cell Therapy, University Hospital of Tours, Tours, France., Chin R; Department of Hemato-Oncology, Institut Paoli Calmette, Marseille, France., Aurran-Schleinitz T; Department of Hemato-Oncology, Institut Paoli Calmette, Marseille, France., Marouf A; Department of Hematology, Cochin Hospital, Paris, France., Deau-Fischer B; Department of Hematology, Cochin Hospital, Paris, France., Coppo P; Department of Hematology and French Reference Center for Thrombotic Microangiopathies, Saint-Antoine Hospital, Paris, France., Malot S; Department of Hematology and French Reference Center for Thrombotic Microangiopathies, Saint-Antoine Hospital, Paris, France., Roussel X; University of France-Comté, Besançon, France., Chauchet A; Department of Hematology, University Hospital of Besançon, Besançon, France., Schwarz M; University of Angers, Angers, France., Bescond C; Department of Hematology, University Hospital of Angers, Angers, France., Lamy de la Chapelle T; Department of Clinical Hematology, University Hospital of Rennes, Rennes, France., Bussot L; University of Grenoble, Grenoble, France., Carras S; Department of Hematology, University Hospital of Grenobles Alpes, Grenoble, France., Burlet B; University of Dijon, Dijon, France., Rossi C; Department of Clinical Hematology, University Hospital of Dijon, Dijon, France., Daniel A; University of Lille, Lille, France., Morschhauser F; Department of Hematology, University Hospital of Lille, Lille, France., Subtil F; Department of Biostatistics, Hospices Civils de Lyon, Lyon, France., Michallet AS; Department of Hematology and Medical Oncology, Centre Léon Bérard, Lyon, France.
Publikováno v:
American journal of hematology [Am J Hematol] 2021 Mar 01; Vol. 96 (3), pp. 302-311. Date of Electronic Publication: 2020 Dec 29.
Autor:
Delarue M; Centre Hospitalier Universitaire de Besançon, Service de chirurgie maxillo-faciale, 25030, Besançon, France. Electronic address: delaruecardinaud@hotmail.com., Berceanu A; Centre Hospitalier Universitaire de Besançon, Service de Soins Intensifs Hématologie, 25030, Besançon, France., Laude MC; Centre Hospitalier Universitaire de Besançon, Service de Soins Intensifs Hématologie, 25030, Besançon, France., Louvrier A; Centre Hospitalier Universitaire de Besançon, Service de chirurgie maxillo-faciale, 25030, Besançon, France; INSERM, EFS BFC, UMR 1098, Interactions hôte-greffon-tumeur - Ingénierie cellulaire et génique, Université de Bourgogne Franche-Comté, Besançon, France.
Publikováno v:
Journal of stomatology, oral and maxillofacial surgery [J Stomatol Oral Maxillofac Surg] 2019 Nov; Vol. 120 (5), pp. 497-498. Date of Electronic Publication: 2019 Jan 18.
Autor:
Heiblig M; Clinical Hematology, Hospices Civils de Lyon, Lyon-Sud Hospital, Pierre-Bénite, France., Elhamri M; Clinical Research Unit, Pierre-Bénite, France., Le Jeune C; Clinical Hematology, Hospices Civils de Lyon, Lyon-Sud Hospital, Pierre-Bénite, France., Laude MC; Clinical Hematology, Hospices Civils de Lyon, Lyon-Sud Hospital, Pierre-Bénite, France., Deloire A; Clinical Research Unit, Pierre-Bénite, France., Wattel E; Clinical Hematology, Hospices Civils de Lyon, Lyon-Sud Hospital, Pierre-Bénite, France., Salles G; Clinical Hematology, Hospices Civils de Lyon, Lyon-Sud Hospital, Pierre-Bénite, France., Thomas X; Clinical Hematology, Hospices Civils de Lyon, Lyon-Sud Hospital, Pierre-Bénite, France.
Publikováno v:
European journal of haematology [Eur J Haematol] 2017 Feb; Vol. 98 (2), pp. 134-141. Date of Electronic Publication: 2016 Oct 12.
Autor:
Cortese, Matthew J.1 (AUTHOR), Wei, Wei2 (AUTHOR), Cerdeña, Sebastian3 (AUTHOR), Watkins, Marcus P.3 (AUTHOR), Olson, Marissa3 (AUTHOR), Jodon, Gray4 (AUTHOR), Kaiser, Jeff4 (AUTHOR), Haverkos, Bradley4 (AUTHOR), Hughes, Mitchell E.5 (AUTHOR), Namoglu, Esin5 (AUTHOR), Grover, Natalie S.6 (AUTHOR), Snow, Anson6 (AUTHOR), Orellana-Noia, Victor7 (AUTHOR), Rainey, Magdalena8 (AUTHOR), Sohail, Mohammad8 (AUTHOR), Rudoni, Joslyn9 (AUTHOR), Portell, Craig7 (AUTHOR), Voorhees, Timothy6 (AUTHOR), Landsburg, Daniel J.5 (AUTHOR), Kamdar, Manali4 (AUTHOR)
Publikováno v:
Leukemia & Lymphoma. Jan2023, Vol. 64 Issue 1, p107-118. 12p.
Autor:
Zhuang, Yuxin1,2 (AUTHOR), Che, Jinxin2,3 (AUTHOR), Wu, Meijuan4 (AUTHOR), Guo, Yu3 (AUTHOR), Xu, Yongjin1 (AUTHOR), Dong, Xiaowu2,3,5 (AUTHOR) dongxw@zju.edu.cn, Yang, Haiyan1 (AUTHOR) yanghy@zjcc.org.cn
Publikováno v:
Journal of Hematology & Oncology. 3/18/2022, Vol. 15 Issue 1, p1-38. 38p.
Autor:
SRETENOVIĆ, Snežana1,2 sretenovicsnezana@yahoo.com, ĐURĐEVIĆ, Predrag1,2
Publikováno v:
Medical Review / Medicinski Pregled. 2022 Supplement, Vol. 75, p88-95. 8p.
Autor:
de Jonge, A. V., Bult, J. A. A., Karssing, D. F. E., Nijland, M., Chamuleau, M. E. D., Brink, M.
Publikováno v:
Blood Cancer Journal; 1/4/2024, Vol. 14 Issue 1, p1-9, 9p